fda warning compounded semaglutide Ozempic, Users Ignore on Compound Drugs FDA issues warning about some

The foundational mechanism papers from the Washington State University lab that described how Dihexa works were retracted in April 2025 following a misconduct finding, with a third paper under an Expression of Concern since 2021

Our study identifies a set of agents with specific GLP-1R trafficking profiles and the potential for greater efficacy and tolerability as T2D treatments

Managing the ramp-up period carefully, starting at a low dose and escalating slowly, is typically the approach providers use to sort this out

Busquets S, Serpe R, Toledo M, Betancourt A, Marmonti E, Orpi M, Pin F, Capdevila E, Madeddu C, Lopez-Soriano FJ, et al